Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo‐Controlled Trial in Adults With Systemic Sclerosis
2020 · Arthritis & Rheumatology · 101 citations
https://doi.org/10.1002/art.41294
J
Jessica Gordon
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
157
Papers
4.1K
Citations
33
h-index
74
i10-index
Jessica Gordon is an academic researcher from Hospital for Special Surgery. The author has contributed to research in topics: Systemic Sclerosis and Related Diseases & Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis & Dermatologic Treatments and Research. The author has an h-index of 33, co-authored 134 publications.
ORCID: 0000-0001-8068-0592Papers by this author
worksNilotinib (Tasigna™) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial
2015 · Arthritis Research & Therapy · 93 citations
https://doi.org/10.1186/s13075-015-0721-3
Clinical characteristics, visceral involvement, and mortality in at-risk or early diffuse systemic sclerosis: a longitudinal analysis of an observational prospective multicenter US cohort
2021 · Arthritis Research & Therapy · 65 citations
https://doi.org/10.1186/s13075-021-02548-1
Changes in mental health symptoms from pre-COVID-19 to COVID-19 among participants with systemic sclerosis from four countries: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort study
2020 · Journal of Psychosomatic Research · 44 citations
https://doi.org/10.1016/j.jpsychores.2020.110262
Progressive loss of conserved spike protein neutralizing antibody sites in Omicron sublineages is balanced by preserved T cell immunity
2023 · Cell Reports · 32 citations
https://doi.org/10.1016/j.celrep.2023.112888
Protocol for a partially nested randomised controlled trial to evaluate the effectiveness of the scleroderma patient-centered intervention network COVID-19 home-isolation activities together (SPIN-CHAT) program to reduce anxiety among at-risk scleroderma patients
2020 · Journal of Psychosomatic Research · 30 citations
https://doi.org/10.1016/j.jpsychores.2020.110132
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat